Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China

BACKGROUND: Colistin is being administered as last-line therapy for patients that have failed to respond to other available antibiotics that are active against Escherichia coli. The underlying mechanisms of colistin resistance and heteroresistance remain largely uncharacterized. The present study in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Drug Resist
Hlavní autoři: Liao, Wenli, Lin, Jie, Jia, Huaiyu, Zhou, Cui, Zhang, Ying, Lin, Yishuai, Ye, Jianzhong, Cao, Jianming, Zhou, Tieli
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553605/
https://ncbi.nlm.nih.gov/pubmed/33116674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S273784
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky